vs

Side-by-side financial comparison of Abbott Laboratories (ABT) and Visa Inc. (V). Click either name above to swap in a different company.

Abbott Laboratories is the larger business by last-quarter revenue ($11.5B vs $11.2B, roughly 1.0× Visa Inc.). Visa Inc. runs the higher net margin — 53.4% vs 15.5%, a 37.9% gap on every dollar of revenue. On growth, Visa Inc. posted the faster year-over-year revenue change (17.0% vs 4.4%). Over the past eight quarters, Visa Inc.'s revenue compounded faster (12.3% CAGR vs 7.2%).

Abbott Laboratories, commonly known as Abbott, is an American multinational medical devices and health care company with headquarters in Abbott Park, Illinois. The company produces pharmaceuticals for sale outside the United States, diagnostic products, nutritional products, and medical devices.

Visa Inc. is an American multinational payment card services corporation headquartered in San Francisco, California. It facilitates electronic funds transfers throughout the world, most commonly through Visa-branded credit cards, debit cards and prepaid cards.

ABT vs V — Head-to-Head

Bigger by revenue
ABT
ABT
1.0× larger
ABT
$11.5B
$11.2B
V
Growing faster (revenue YoY)
V
V
+12.6% gap
V
17.0%
4.4%
ABT
Higher net margin
V
V
37.9% more per $
V
53.4%
15.5%
ABT
Faster 2-yr revenue CAGR
V
V
Annualised
V
12.3%
7.2%
ABT

Income Statement — Q4 FY2025 vs Q2 FY2026

Metric
ABT
ABT
V
V
Revenue
$11.5B
$11.2B
Net Profit
$1.8B
$6.0B
Gross Margin
57.0%
Operating Margin
19.6%
64.4%
Net Margin
15.5%
53.4%
Revenue YoY
4.4%
17.0%
Net Profit YoY
-80.8%
32.0%
EPS (diluted)
$1.01

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ABT
ABT
V
V
Q2 26
$11.2B
Q4 25
$11.5B
$10.9B
Q3 25
$11.4B
$10.7B
Q2 25
$11.1B
$10.2B
Q1 25
$10.4B
$9.6B
Q4 24
$11.0B
$9.5B
Q3 24
$10.6B
$9.6B
Q2 24
$10.4B
$8.9B
Net Profit
ABT
ABT
V
V
Q2 26
$6.0B
Q4 25
$1.8B
$5.9B
Q3 25
$1.6B
$5.1B
Q2 25
$1.8B
$5.3B
Q1 25
$1.3B
$4.6B
Q4 24
$9.2B
$5.1B
Q3 24
$1.6B
$5.3B
Q2 24
$1.3B
$4.9B
Gross Margin
ABT
ABT
V
V
Q2 26
Q4 25
57.0%
Q3 25
55.4%
Q2 25
56.4%
Q1 25
56.9%
Q4 24
55.0%
Q3 24
55.8%
Q2 24
55.6%
Operating Margin
ABT
ABT
V
V
Q2 26
64.4%
Q4 25
19.6%
61.8%
Q3 25
18.1%
57.3%
Q2 25
18.4%
60.7%
Q1 25
16.3%
56.6%
Q4 24
17.4%
65.6%
Q3 24
17.5%
66.0%
Q2 24
16.1%
66.7%
Net Margin
ABT
ABT
V
V
Q2 26
53.4%
Q4 25
15.5%
53.7%
Q3 25
14.5%
47.5%
Q2 25
16.0%
51.8%
Q1 25
12.8%
47.7%
Q4 24
84.1%
53.8%
Q3 24
15.5%
55.3%
Q2 24
12.5%
54.7%
EPS (diluted)
ABT
ABT
V
V
Q2 26
Q4 25
$1.01
Q3 25
$0.94
Q2 25
$1.01
Q1 25
$0.76
Q4 24
$5.26
Q3 24
$0.94
Q2 24
$0.74

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ABT
ABT
V
V
Cash + ST InvestmentsLiquidity on hand
$8.9B
$12.4B
Total DebtLower is stronger
$12.9B
$22.4B
Stockholders' EquityBook value
$52.1B
$35.7B
Total Assets
$86.7B
$95.0B
Debt / EquityLower = less leverage
0.25×
0.63×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ABT
ABT
V
V
Q2 26
$12.4B
Q4 25
$8.9B
$14.8B
Q3 25
$7.7B
$17.2B
Q2 25
$7.3B
$17.1B
Q1 25
$6.8B
$11.7B
Q4 24
$8.0B
$12.4B
Q3 24
$7.8B
$12.0B
Q2 24
$7.2B
$12.9B
Total Debt
ABT
ABT
V
V
Q2 26
$22.4B
Q4 25
$12.9B
Q3 25
Q2 25
Q1 25
Q4 24
$14.1B
Q3 24
Q2 24
Stockholders' Equity
ABT
ABT
V
V
Q2 26
$35.7B
Q4 25
$52.1B
$38.8B
Q3 25
$51.0B
$37.9B
Q2 25
$50.6B
$38.7B
Q1 25
$48.8B
$38.0B
Q4 24
$47.7B
$38.3B
Q3 24
$39.8B
$39.1B
Q2 24
$39.3B
$39.7B
Total Assets
ABT
ABT
V
V
Q2 26
$95.0B
Q4 25
$86.7B
$96.8B
Q3 25
$84.2B
$99.6B
Q2 25
$84.0B
$100.0B
Q1 25
$81.4B
$92.9B
Q4 24
$81.4B
$91.9B
Q3 24
$74.4B
$94.5B
Q2 24
$73.0B
$91.0B
Debt / Equity
ABT
ABT
V
V
Q2 26
0.63×
Q4 25
0.25×
Q3 25
Q2 25
Q1 25
Q4 24
0.30×
Q3 24
Q2 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ABT
ABT
V
V
Operating Cash FlowLast quarter
$3.3B
Free Cash FlowOCF − Capex
$2.6B
FCF MarginFCF / Revenue
22.9%
Capex IntensityCapex / Revenue
6.0%
Cash ConversionOCF / Net Profit
1.87×
TTM Free Cash FlowTrailing 4 quarters
$7.4B

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ABT
ABT
V
V
Q2 26
Q4 25
$3.3B
$6.8B
Q3 25
$2.8B
$6.2B
Q2 25
$2.0B
$6.7B
Q1 25
$1.4B
$4.7B
Q4 24
$2.9B
$5.4B
Q3 24
$2.7B
$6.7B
Q2 24
$2.0B
$5.1B
Free Cash Flow
ABT
ABT
V
V
Q2 26
Q4 25
$2.6B
$6.4B
Q3 25
$2.3B
$5.8B
Q2 25
$1.5B
$6.3B
Q1 25
$933.0M
$4.4B
Q4 24
$2.1B
$5.1B
Q3 24
$2.1B
$6.4B
Q2 24
$1.4B
$4.7B
FCF Margin
ABT
ABT
V
V
Q2 26
Q4 25
22.9%
58.7%
Q3 25
20.2%
54.5%
Q2 25
13.9%
62.0%
Q1 25
9.0%
45.5%
Q4 24
19.6%
53.1%
Q3 24
20.2%
66.1%
Q2 24
13.8%
53.2%
Capex Intensity
ABT
ABT
V
V
Q2 26
Q4 25
6.0%
3.5%
Q3 25
4.4%
3.6%
Q2 25
4.5%
4.1%
Q1 25
4.7%
3.4%
Q4 24
6.6%
3.6%
Q3 24
5.2%
3.2%
Q2 24
5.1%
4.5%
Cash Conversion
ABT
ABT
V
V
Q2 26
Q4 25
1.87×
1.16×
Q3 25
1.70×
1.23×
Q2 25
1.15×
1.28×
Q1 25
1.07×
1.03×
Q4 24
0.31×
1.05×
Q3 24
1.64×
1.25×
Q2 24
1.51×
1.05×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

ABT
ABT

Segment breakdown not available.

V
V

Data processing revenue$5.5B49%
International transaction revenue$3.6B32%
Other revenue$1.3B12%
Other$736.0M7%

Related Comparisons